These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 117669)

  • 1. The EEG effects of thyreotropin releasing hormone in healthy subjects and chronic schizophrenics.
    Hynek K; Filip V
    Act Nerv Super (Praha); 1979 Oct; 21(3):173-4. PubMed ID: 117669
    [No Abstract]   [Full Text] [Related]  

  • 2. TRH treatment in psychiatric patients--effects on the pituitary-thyroid axis and on the EEG sleep pattern.
    Cassano GB; Castrogiovanni P; Maggini C
    Psychopharmacol Bull; 1975 Oct; 11(4):66-7. PubMed ID: 812137
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyrotropin releasing hormone in depression and schizophrenia.
    Hollister LE; Berger P; Ogle FL; Arnold RC; Johnson A
    Psychopharmacol Bull; 1975 Jan; 11(1):27-28. PubMed ID: 804706
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyrotropin-releasing hormone in schizophrenia.
    Davis KL; Hossister LE; Berger PA
    Am J Psychiatry; 1975 Sep; 132(9):951-3. PubMed ID: 808141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of synthetic "thyreotropin releasing factor" on the plasma levels of thyreotropic hormone and growth hormone in healthy subjects, in patients with hyperthyreosis and primary hypothyreosis].
    zur Mühlen A von ; Hesch RD; Emrich D; Creutzfeldt W
    Dtsch Med Wochenschr; 1970 Dec; 95(52):2623-4. PubMed ID: 4098875
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthetic thyroid releasing hormone (TRH) administered orally to chronic schizophrenic patients.
    Clark ML; Paredes A; Costiloe JP; Wood F
    Psychopharmacol Commun; 1975; 1(2):191-200. PubMed ID: 817373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: Thyrotropin-releasing hormone in chronic schizophrenia.
    Bigelow LB; Gillin JC; Semal C; Wyatt RJ
    Lancet; 1975 Nov; 2(7940):869-70. PubMed ID: 53351
    [No Abstract]   [Full Text] [Related]  

  • 8. EEG signs of toxicity in schizophrenics on phenothiazines.
    Emde RN; Metcalf DR
    Behav Neuropsychiatry; 1969 Nov; 1(8):31-6. PubMed ID: 5374544
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of perphenazine and P-5227 in chronic schizophrenics: clinical and EEG effects.
    Holden JM; Itil TM; Keskiner A
    J Clin Pharmacol J New Drugs; 1969; 9(3):163-75. PubMed ID: 5255181
    [No Abstract]   [Full Text] [Related]  

  • 10. A treatment trial with an analog of thyrotropin-releasing hormone (DN-1417) in schizophrenia.
    Mizuki Y; Nishikori S; Kajimura N; Imaizumi J; Yamada M; Inanaga K
    Biol Psychiatry; 1985 Sep; 20(9):1030-5. PubMed ID: 2862926
    [No Abstract]   [Full Text] [Related]  

  • 11. [EEG and the action of TRH: comparison with amitriptyline].
    Bramanti P; Meduri M; Bianchi L; Di Perri R
    Boll Soc Ital Biol Sper; 1980 Dec; 56(23):2467-72. PubMed ID: 6781506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Electrophysiological findings after TRH-T administration to healthy volunteers].
    Bramanti P; Di Bella P; Ricci RM; De Luca GP; De Leo M; Di Perri R
    Clin Ter; 1990 Mar; 132(6):405-8. PubMed ID: 2139386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of DN-1417 (TRH analog) on schizophrenic patients].
    Mizuki Y; Takada Y; Tsujimaru H; Takii O; Nishijima H
    Seishin Shinkeigaku Zasshi; 1983; 85(11):808-12. PubMed ID: 6146149
    [No Abstract]   [Full Text] [Related]  

  • 14. Luteinizing hormone-releasing hormone and thyrotropin-releasing hormone stimulation studies in patients given clomipramine or 'depot' neuroleptics.
    Huws D; Groom GV
    Postgrad Med J; 1977; 53 Suppl 4():175-81. PubMed ID: 414217
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of single oral doses of trace elements on the quantitated EEG of normal subjects and chronic schizophrenics [proceedings].
    Goldstein L; Pfeiffer CC
    Psychopharmacol Bull; 1978 Jul; 14(3):55-7. PubMed ID: 674538
    [No Abstract]   [Full Text] [Related]  

  • 16. [Theoretical principles and personal experiences in the use of a sequential stimulation test with arginine, gonadotropin-releasing hormone and thyrotropin-releasing hormone in healthy probands].
    Rudolf K; Kunkel S; Rudolf H; Rüting M; Töwe J
    Zentralbl Gynakol; 1985; 107(21):1282-95. PubMed ID: 3936306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predicting the effects of haloperidol on schizophrenics by quantitative pharmaco-EEG].
    Zhang XL
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Oct; 25(5):300-2, 318. PubMed ID: 1291253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSH response to TRH stimulation in major depression: relationship to clinical and sleep EEG variables.
    Hubain P; Staner L; Dramaix M; Rielart C; Papadimitriou G; Linkowski P; Mendlewicz J
    Acta Psychiatr Belg; 1992; 92(3):180. PubMed ID: 1345433
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possibilities in the use of thyrotropin-releasing hormone (TRH)].
    Retiene K; Schulz F; Müller A
    Med Klin; 1973 Sep; 68(36):1146-50. PubMed ID: 4199832
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of thyrotropin releasing hormone (TRH) in normal subjects and in patients with thyroid gland diseases].
    Lauridsen UB; Friis T; Kirkegaard C; Hansen JM; Siersbaek-Nielsen K
    Ugeskr Laeger; 1974 Jun; 136(25):1360-4. PubMed ID: 4210165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.